The founders of CreOsso have worked as partners in an academic practice as well as research collaborators for nearly 20 years. After licensing the rights to their research work product at UMDNJ (now Rutgers University), they decided to take on the challenge of moving from basic science to applied research in the development of products that could help them and their orthopedic colleagues in the treatment of patients.
Joseph Benevenia, M.D.
Sheldon Lin, M.D.
Michael Vives, M.D.
Joseph Benevenia, M.D. - Founder and Managing Partner
Joseph Benevenia, M.D. is Orthopaedics Chief of Service at University Hospital and Professor and Chair of Orthopaedics at Rutgers, New Jersey Medical School. He specializes in Musculoskeletal Oncology with subspecialty interests that include bone and soft-tissue tumors, allograft and endoprosthetic reconstructions, and limb-salvage surgeries. His research interests include the utilization of prostheses, the use of bone allografts, and tumor enhancing bone healing. Dr. Benevenia has received numerous awards for his research and academic achievements and has been recognized as a Top Doctor in the New York Metro Area for the past twelve years. He is a sought after reviewer for prestigious medical journals in the field of Orthopaedics such as Journal of Bone and Joint Surgery, Clinical Orthopaedics and Related Research, and the Journal of the American Academy of Orthopaedic Surgeons. His outstanding reputation has allowed him to serve on numerous committees and in various roles for national organizations including Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties, New Jersey Orthopaedic Society, and numerous committees within the American Academy of Orthopaedic Surgeons (AAOS) and the Musculoskeletal Tumor Society (MSTS). He currently serves on the Executive Committee of the Musculoskeletal Tumor Society.
Sheldon Lin, M.D. - Founder and Managing Partner
Sheldon Lin, M.D. is chief of Foot Ankle Division and Associate Professor of the Department of Orthopedics at Rutgers-New Jersey Medical School. He has extensive clinical experience in lower extremity, with specific focus on foot and ankle trauma and fusions. Dr. Lin’s expertise has earned him the position of Associate Editor of Foot Ankle International as well as section editor for OKU Foot Ankle I and II . In addition, he has been Chairperson of the AOFAS Research Committee, OREF Prospective Clinical Research as well as currently Chair for the ORS Awards committee and reviewer for DOD CDMRP. He also has served as Program Director for the Orthobiologic Symposium at the AOFAS Pre-meeting in 2012.
His research interests have focused on the role of insulin and insulin mimetic agents upon bone healing. With his previous experience in Pre-clinical and Clinical FDA trials (BioMimetic Therapeutics/Wright Medical) in orthobiologic agents, he has developed an orthobiologic platform supported by multiple publications and presentations demonstrating its potential clinical application in fusions (hindfoot, spine), fracture healing(implantable and injectable options) and segmental defects. This technology platform has been built upon a strong IP portfolio, with several issued (US and Europe) and pending patents in the International forum.
In 2013, Dr Lin and Dr. Joseph Benevenia, obtained a license from UMDNJ/Rutgers University with the goal of developing and commercializing their research work, thus enabling the establishment of CreOsso.
Michael Vives, M.D. - Partner
Michael Vives, M.D. is the Chief of the Spine Division and an Associate Professor in the Department of Orthopedics at Rutgers-New Jersey Medical School. He has extensive experience in the operative and non-operative treatment for a wide range of spinal disorders including degenerative conditions, scoliosis, spinal fractures/spinal cord injury, and spinal tumors/infections. Dr. Vives’ expertise has earned him positions on the advisory editorial board of The Spine Journal, on the review/editorial board of The Journal of Spinal Cord Medicine, and as a section editor for SpineLine. He recently completed two terms as Chairman of the Scientific Program for Spine for the American Academy of Orthopaedic Surgeons (AAOS) and has served multiple years as a member of the Scientific Program Committee for the North American Spine Society (NASS). His research interests include the biomechanics of cervical injuries and their treatment constructs, the development of screening items and scoring systems for cervical myelopathy, and treatments and trends in the management of spinal fractures. He has a longstanding interest in the biology of spinal fusion and has broad experience in the use of animal models in translational spine research.
Steven Hirsch - Business Manager
Steven Hirsch has spent 35 years in the medical device industry, including marketing, sales and general management positions with Howmedica and Smith and Nephew Orthopedics. As the SVP and General Manager of the worldwide total joint replacement business for Smith and Nephew, Mr. Hirsch had P&L responsibility for a $700M business unit and led a 40% growth in worldwide sales over a three year period. Mr. Hirsch spent 5 years with biotech start-up Biomimetic Therapeutics, serving as COO and head of the orthopedics business. In this role he had responsibility for marketing and commercialization, clinical, quality and regulatory functions. For the past 2 years, he has been working with the founders of CreOsso providing advice on organizing the business and the development of a strategic plan.